http://orcid.org/0000-0003-4678-2469
Correction
3 Aug 2020: Schleenvoigt BT, Theis B, Wüst M, Forstner C, Pletz MW, et al. (2020) Correction: Intermittent pain of the pelvis in a Syrian woman. PLOS Neglected Tropical Diseases 14(8): e0008569. https://doi.org/10.1371/journal.pntd.0008569 View correction
Figures
Citation: Schleenvoigt BT, Theis B, Wüst M, Forstner C, Pletz MW, Hagel S (2020) Intermittent pain of the pelvis in a Syrian woman. PLoS Negl Trop Dis 14(6): e0008183. https://doi.org/10.1371/journal.pntd.0008183
Editor: Zvi Bentwich, Ben-Gurion University of the Negev, ISRAEL
Published: June 18, 2020
Copyright: © 2020 Schleenvoigt et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors received no specific funding for this work.
Competing interests: The authors have no conflicts of interest to declare.
Presentation of case
A 66-year-old immunocompetent woman from Syria presented with a two-months history of intermittent pain of the right pelvis to the Jena University Hospital (Germany). Fever, night sweats and weight loss were denied. An MRI scan of the pelvis showed marked destruction of os ilium and os sacrum and a sinus tract draining in multiple subcutaneous cystic lesions (Fig 1 and Fig 2). Erythrocyte sedimentation rate was slightly elevated (30 mm/h), and C-reactive protein and white blood cell count were normal. There was no eosinophilia or Immunoglobulin E (IgE) elevation. To establish diagnosis, a bone biopsy was performed. Histopathology showed loose edematous connective tissue, a mixed inflammatory infiltrate, and regressive calcifications. PAS-positive cuticular components with typical lamellar layering, consistent with echinococcosis were detectable. Furthermore, wall fragments of cystic lesions were visible (Fig 3 and Fig 4). Immunohistochemistry directed against specific antigens of Echinococcus granulosus and E. multilocularis confirmed the former as causative agent. Due to the localization and extensive bone destruction, no surgical excision was possible. Consequently, empirical treatment for tuberculosis was stopped, and therapy with albendazole (400 mg twice daily) was initiated for an indefinite period.
Image credit: S. Gießler. T1, T1-weighted imaging.
Image credit: S. Gießler. T2, T2-weighted imaging.
Image credit: B. Theis. HE, hematoxylin–eosin.
Neither a well-defined germinal epithelium, nor protoscolices were observed, which may indicate an infertile state of the hydatid cyst. Image credit: B. Theis. PAS, Periodic acid–Schiff.
Case discussion
Echinococcosis is a neglected tropical disease recognized by the World Health Organization (WHO). Cystic Echinococcosis (CE) is caused by metacestodes—the larval stage of the species E. granulosus. Adult parasites live in the intestine of the definitive host. These are dogs and other carnivores. The intermediate hosts—usually sheep and other herbivores—get infected by oral intake of the eggs. The human is an intermediate incidental host who can harbor the vesicular metacestode in any anatomical site. The liver is the most frequent location of the fluid filled cystic lesions (70%), followed by the lungs (20%). The central nervous system is affected in 3%. Osseous echinococcosis is a rare disease (1% to 4%). It can involve any bone, but has a predilection for the vertebral column (45%), pelvis (14%), and femur (10%) [1,2]. Multiosseous infestation and concomitant soft tissue or organ involvement are frequent, particularly the combination of proximal femur involvement with the pelvic girdle. In a small study from Kazakhstan including 8 patients with CE of the bone, the pelvis was the predominant localization. In all cases, malignancy was initially suspected [3].
The prevalence of CE in the population of migrants from Middle East countries is not known. Diagnoses relies on imaging, in addition to serology, and occasionally microscopic identification of tissue samples. Ultrasound is the cornerstone for diagnosis, staging, and follow-up. It can be supplemented by computed tomography (CT) and MRI. When ultrasound is unavailable, MRI should be the preferred cut imaging [4]. Diagnosis is often protracted as CE of the bone lacks a typical clinical appearance and image characteristics on X-ray or CT scan are similar to those of tuberculosis, metastases, and giant cell tumors or bone cysts. Complete surgical excision of the lesions combined with albendazole chemotherapy are the standard of care with a 17% risk of recurrence [5]. The dual therapeutic combination of albendazole with praziquantel seems to be more effective than albendazole alone and is occasionally used for therapy of CE [6]. In most cases, complete surgical intervention is not possible and thus the prognosis is very poor. Frequent sequels of the highly destructive parasitic process are chronic pain, pseudarthrosis, fractures, and death [5, 7, 8].
Physicians should be aware of this rare differential diagnosis in cystic bone lesions, especially in migrating populations.
Key learning points
- CE is an important differential diagnosis of cystic bone lesions, especially in migrating populations.
- CE can involve any bone, but has a predilection for the vertebral column (45%), pelvis (14%), and femur (10%).
- In histopathology, PAS-positive cuticular components with typical lamellar layering of the hydatid cyst can be observed in CE.
- If possible, surgical excision of the lesions combined with albendazole chemotherapy are standard of care for CE of the bone.
References
- 1. Agudelo Higuita NI, Brunetti E, McCloskey C. Cystic Echinococcosis. J Clin Microbiol. 2016;54(3):518–23. pmid:26677245; PubMed Central PMCID: PMC4767951.
- 2. Neumayr A, Tamarozzi F, Goblirsch S, Blum J, Brunetti E. Spinal cystic echinococcosis—a systematic analysis and review of the literature: part 2. Treatment, follow-up and outcome. PLoS Negl Trop Dis. 2013;7(9):e2458. pmid:24069501; PubMed Central PMCID: PMC3777903.
- 3. Manciulli T, Mustapayeva A, Juszkiewicz K, Sokolenko E, Maulenov Z, Vola A, et al. Cystic Echinococcosis of the Bone in Kazakhstan. Case Rep Infect Dis. 2018;2018:9682508. pmid:30319824; PubMed Central PMCID: PMC6167588.
- 4. Stojkovic M, Rosenberger K, Kauczor HU, Junghanss T, Hosch W. Diagnosing and staging of cystic echinococcosis: how do CT and MRI perform in comparison to ultrasound? PLoS Negl Trop Dis. 2012;6(10):e1880. pmid:23145199; PubMed Central PMCID: PMC3493391.
- 5. Steinmetz S, Racloz G, Stern R, Dominguez D, Al-Mayahi M, Schibler M, et al. Treatment challenges associated with bone echinococcosis. J Antimicrob Chemother. 2014;69(3):821–6. pmid:24222611.
- 6. Velasco-Tirado V, Alonso-Sardon M, Lopez-Bernus A, Romero-Alegria A, Burguillo FJ, Muro A, et al. Medical treatment of cystic echinococcosis: systematic review and meta-analysis. BMC Infect Dis. 2018;18(1):306. pmid:29976137; PubMed Central PMCID: PMC6034244.
- 7. Cattaneo L, Manciulli T, Cretu CM, Giordani MT, Angheben A, Bartoloni A, et al. Cystic Echinococcosis of the Bone: A European Multicenter Study. Am J Trop Med Hyg. 2019;100(3):617–21. pmid:30693857; PubMed Central PMCID: PMC6402919.
- 8. Monge-Maillo B, Chamorro Tojeiro S, Lopez-Velez R. Management of osseous cystic echinococcosis. Expert Rev Anti Infect Ther. 2017;15(12):1075–82. pmid:29110551.